Biopharma's caution today could put future growth at risk, ZS research finds
<p>New ZS Impact Institute™ research finds biopharma leaders expect continued growth while making decisions that could weaken the innovation needed to sustain it. EVANSTON, Ill., Nov. 16, 2026 /PRNewswire/ -- Biopharma is confident it will grow through 2035, yet new research from the ZS...</p>
Read original article ↗